Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
Scott W. Biggins, P. Angeli, Guadalupe García–Tsao, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 1014-1048
Closed Access | Times Cited: 520

Showing 1-25 of 520 citing articles:

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Wah‐Kheong Chan, Kee Huat Chuah, Ruveena Bhavani Rajaram, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 3, pp. 197-213
Open Access | Times Cited: 274
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, et al.
Hepatology (2022) Vol. 77, Iss. 2, pp. 659-702
Open Access | Times Cited: 166
Diagnosis and Management of Cirrhosis and Its Complications
Elliot B. Tapper, Neehar D. Parikh
JAMA (2023) Vol. 329, Iss. 18, pp. 1589-1589
Closed Access | Times Cited: 155
AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis
David E. Kaplan, Cristina Ripoll, Maja Thiele, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1180-1211
Open Access | Times Cited: 136
The Evolving Challenge of Infections in Cirrhosis
Jasmohan S. Bajaj, Patrick S. Kamath, K. Rajender Reddy
New England Journal of Medicine (2021) Vol. 384, Iss. 24, pp. 2317-2330
Closed Access | Times Cited: 129
AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis
Shari S. Rogal, Lissi Hansen, Arpan Patel, et al.
Hepatology (2022) Vol. 76, Iss. 3, pp. 819-853
Open Access | Times Cited: 108
Acute Kidney Injury in Patients with Cirrhosis
Mitra K. Nadim, Guadalupe García–Tsao
New England Journal of Medicine (2023) Vol. 388, Iss. 8, pp. 733-745
Closed Access | Times Cited: 93
Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants
Veeral Ajmera, Beom Kyung Kim, Kun Yang, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 1079-1089.e5
Open Access | Times Cited: 92
Promises of microbiome-based therapies
Jasmohan S. Bajaj, Siew C. Ng, Bernd Schnabl
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1379-1391
Open Access | Times Cited: 74
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis
Daniel Q. Huang, Nabil Noureddin, Veeral Ajmera, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 9, pp. 829-836
Open Access | Times Cited: 71
Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting
Mitra K. Nadim, John A. Kellum, Lui G. Forni, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 1, pp. 163-183
Open Access | Times Cited: 58
Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US
Kavish R. Patidar, Justin M. Belcher, Kevin R. Regner, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 6, pp. 1408-1417
Closed Access | Times Cited: 46
Infections in cirrhosis
Salvatore Piano, Chalermrat Bunchorntavakul, Sebastián Marciano, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 8, pp. 745-757
Closed Access | Times Cited: 20
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 19
Albumin: a comprehensive review and practical guideline for clinical use
Farshad Abedi, Batool Zarei, Sepideh Elyasi
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 8, pp. 1151-1169
Closed Access | Times Cited: 17
Hepatorenal Syndrome in Cirrhosis
Elisa Pose, Salvatore Piano, Adrià Juanola, et al.
Gastroenterology (2024) Vol. 166, Iss. 4, pp. 588-604.e1
Closed Access | Times Cited: 16
Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Luis Antonio Díaz, Daniel König, Sabine Weber, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 3
Effect of albumin treatment duration on response rates and outcomes in patients with cirrhosis and acute kidney injury
Eva Maria Schleicher, Henrik Karbannek, Julia Weinmann‐Menke, et al.
Journal of Hepatology (2025)
Open Access | Times Cited: 2
AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review
Steven L. Flamm, Florence Wong, Joseph Ahn, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 12, pp. 2707-2716
Closed Access | Times Cited: 58
The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions
Pierre Deltenre, Alberto Zanetto, Dario Saltini, et al.
Hepatology (2022) Vol. 77, Iss. 2, pp. 640-658
Open Access | Times Cited: 44
Long-term albumin treatment in patients with cirrhosis and ascites
Paolo Caraceni, Alastair O’Brien, Pere Ginés
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1306-1317
Open Access | Times Cited: 41
AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis
Constantine Karvellas, Jasmohan S. Bajaj, Patrick S. Kamath, et al.
Hepatology (2023) Vol. 79, Iss. 6, pp. 1463-1502
Open Access | Times Cited: 38
Update in the Treatment of the Complications of Cirrhosis
Juan G. Abraldeṣ, Paolo Caraceni, Marwan Ghabril, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2100-2109
Open Access | Times Cited: 36
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies
Michael P. Curry, Hugo E. Vargas, Alex S. Befeler, et al.
Hepatology Communications (2023) Vol. 7, Iss. 1, pp. e1307-e1307
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top